Avance Clinical is excited to announce our participation in BIO KOREA 2025, scheduled from May 7 to 9 at COEX in Seoul. This annual convention has been a cornerstone for the global bio-health industry since 2006, offering a platform for exchanging the latest trends and technologies.
This event marks the 20th iteration of BIO KOREA and is recognized as Korea’s largest international life sciences convention, organized by the Korea Health Industry Development Institute (KHIDI).
Avance Clinical will be represented by the following team members.
Their presence underscores the company’s commitment to fostering collaborations within the Korean bio-health sector.
In October 2024, Avance Clinical’s CEO, Yvonne Lungershausen, and Jessica Han formalized partnerships with prominent Korean institutions, including CHA University Bundang Medical Center, Korea University Medicine, and Dong-A University Hospital. These Memorandums of Understanding (MOUs) enhance our capacity to offer flexible and efficient clinical trial services across the Asia-Pacific region.
Jessica Han, based in Seoul, brings over 17 years of experience in healthcare and clinical research. Her leadership is pivotal in driving our operations and strategic initiatives across Asia.
Kelly Yang, with over 15 years in the pharmaceutical and clinical research industries, leads our operations in Taiwan. Her expertise in clinical operations and project management strengthens our presence in the region.
Our participation in BIO KOREA 2025 reflects our dedication to advancing clinical research in South Korea. We look forward to engaging with industry leaders and exploring new opportunities to drive growth in the bio-health sector.
Avance Clinical is a full-service Contract Research Organization (CRO) with clinical operations in Australia, New Zealand, Asia, North America, and Europe.
Level 22, 91 King William Street
Adelaide, SA
Australia 5000
Phone: +61 8 8249 4788
For all media enquiries: media@avancecro.com
